“…The ability of SIRT1 to promote ovarian cell proliferation and IGF-I release, as well as to promote FSH action on these processes (from [23]) is illustrated by Figure 1. Fu et al [27] reported the involvement of another SIRT—SIRT3—in the up-regulation of genes involved in human ovarian folliculo-, luteo-, and steroidogenesis: knockdown of SIRT3 resulted in decreased expression of aromatase, 17β-hydroxysteroid dehydrogenase 1, steroidogenic acute regulatory protein, cholesterol side-chain cleavage enzyme, and 3β-hydroxysteroid dehydrogenase in granulosa cells, and decreased their progesterone release. Aside from mTOR, SIRTs can affect ovarian cell functions via changes in the production of transcription factors p53, NFkB [18,23,25], FOXL2 [28], Noch 3 [29], STAT3, steroid hormone receptors, and other intracellular signaling molecules [5], which in turn affect ovarian proliferation, apoptosis, and steroidogenesis.…”